Japan, April 9 -- LEPU BIOPHARMA CO LTD has got intellectual property rights for 'BIFUNCTIONAL MOLECULES TARGETING PD-L1 AND TGF-BETA.' Other related details are as follows:
Application Number: JP,2024-187749
Category (FI): A61K38/17,A61K39/395@N,A61K39/395@U,A61K47/55,A61K47/62,A61K47/68,A61P35/00,A61P35/02,A61P37/04,C07K14/705,C07K16/00,C07K16/28,C07K19/00,C12N1/15,C12N1/19,C12N1/21,C12N15/12,C12N15/13,C12N15/62@P,C12N5/10,C12P21/00@C,C12P21/00@Z,C12P21/08
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Oct. 24, 2024
Publication Date: Jan. 20, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
